Haemonetics Corporation (HAE)

Current ratio

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Total current assets	US$ in thousands	934,975	768,903	769,722	756,031	693,546
Total current liabilities	US$ in thousands	578,113	300,383	251,816	442,266	253,495
Current ratio		1.62	2.56	3.06	1.71	2.74

March 31, 2025 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $934,975K ÷ $578,113K
= 1.62

The current ratio of Haemonetics Corporation has exhibited fluctuations over the years. In March 31, 2021, the current ratio was 2.74 indicating a healthy level of liquidity. However, by March 31, 2022, the ratio declined to 1.71, suggesting a potential strain on short-term liquidity.

It improved significantly by March 31, 2023, reaching 3.06, reflecting a robust ability to cover short-term obligations. The ratio decreased slightly to 2.56 by March 31, 2024, but still remained at a reasonable level.

Unfortunately, data for March 31, 2025 is not available.

Overall, the trend in the current ratio of Haemonetics Corporation highlights both strengths and potential vulnerabilities in managing its short-term liabilities in the specified period.